PatientsVille.com Logo

PatientsVille

Cymbalta Side Effects

Common Cymbalta Side Effects

The most commonly reported Cymbalta side effects (click to view or check a box to report):

Nausea (1362)
Dizziness (1252)
Headache (900)
Feeling Abnormal (847)
Fatigue (734)
Depression (731)
Insomnia (721)
Anxiety (624)
Alanine Aminotransferase Increased (619)
Paraesthesia (558)
Hyperhidrosis (557)
Diarrhoea (546)
Aspartate Aminotransferase Increased (536)
Suicidal Ideation (503)
Hepatic Enzyme Increased (466)
Blood Pressure Increased (463)
Vomiting (431)
Loss Of Consciousness (427)
Fall (422)
Asthenia (420)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Cymbalta Side Effects Reported to FDA

The following Cymbalta reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Cymbalta on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Dysphagia, Nausea, Dizziness, Hallucination, Paraesthesia, Muscle Spasms, Chills, Pain
on Mar 11, 2014 Female from US , 33 years of age, weighting 180.0 lb, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: dysphagia, nausea, dizziness, hallucination, paraesthesia, muscle spasms, chills, pain. Cymbalta dosage: 1 Pill 1 Time Per Day.

Lethargy, Myalgia, Headache, Nausea, Vomiting
Patient was taking Cymbalta. Patient felt the following Cymbalta side effects: lethargy, myalgia, headache, nausea, vomiting on Mar 12, 2014 from US Additional patient health information: Male , weighting 170.0 lb, . Cymbalta dosage: 30 Mg, Bid. Patient was hospitalized.

Halo Vision, Aura, Impaired Work Ability, Dry Mouth, Dry Eye, Gait Disturbance, Hypertension
Adverse event was reported on Mar 11, 2014 by a Female taking Cymbalta (Dosage: 1 X Night) was diagnosed with and. Location: US , 64 years of age, weighting 157.0 lb, After Cymbalta was administered, patient encountered several Cymbalta side effects: halo vision, aura, impaired work ability, dry mouth, dry eye, gait disturbance, hypertension.

Asthma, Off Label Use
on Mar 11, 2014 Female from GB , 40 years of age, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: asthma, off label use. Cymbalta dosage: 60 Mg, Qd. Patient was hospitalized.


Nightmare, Hypoaesthesia, Paraesthesia, Hyperhidrosis, Nausea, Feeling Cold, Pain
on Mar 10, 2014 Female from US , 42 years of age, weighting 135.0 lb, was treated with Cymbalta. Patient felt the following Cymbalta side effects: nightmare, hypoaesthesia, paraesthesia, hyperhidrosis, nausea, feeling cold, pain. Cymbalta dosage: N/A.

Dysphemia, Paraesthesia, Nausea, Anxiety, Emotional Distress, Weight Increased
Patient was taking Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: dysphemia, paraesthesia, nausea, anxiety, emotional distress, weight increased on Mar 10, 2014 from US Additional patient health information: Male , 40 years of age, weighting 390.0 lb, was diagnosed with and. Cymbalta dosage: 1 Time Daily Once Daily Taken By Mouth.

Deep Vein Thrombosis, Gallbladder Non-functioning, Depression, Pain, Memory Impairment
Adverse event was reported on Mar 10, 2014 by a Female taking Cymbalta (Dosage: By Mouth) was diagnosed with and. Location: US , 29 years of age, weighting 155.0 lb, Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: deep vein thrombosis, gallbladder non-functioning, depression, pain, memory impairment. Patient was hospitalized.

Product Substitution Issue
on Mar 10, 2014 Female from US , 50 years of age, weighting 185.4 lb, was diagnosed with and was treated with Cymbalta. Patient felt the following Cymbalta side effects: product substitution issue. Cymbalta dosage: 30 Mg Daily Oral?approx 1-2 Months.

Contusion, Abdominal Pain
on Mar 10, 2014 Patient from US , 53 years of age, was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: contusion, abdominal pain. Cymbalta dosage: N/A.

Hyponatraemia, Pituitary Haemorrhage
Patient was taking Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: hyponatraemia, pituitary haemorrhage on Mar 31, 2014 from JP Additional patient health information: Female , 70 years of age, weighting 97.00 lb, was diagnosed with and. Cymbalta dosage: 20 Mg, Bid.
Associated medications used:
  • Magmitt (330 Mg, Tid)


Delirium, Hyponatraemia, Confusional State, Muscle Twitching, Somnolence, Off Label Use
Adverse event was reported on Mar 11, 2014 by a Female taking Cymbalta (Dosage: 30 Mg, Each Evening) was diagnosed with and. Location: GB , 71 years of age, weighting 141.0 lb, Patient felt the following Cymbalta side effects: delirium, hyponatraemia, confusional state, muscle twitching, somnolence, off label use.
Multiple prescriptions taken:
  • Bendroflumethiazide (Unk)
  • Co-dydramol (Unk)
  • Durogesic (Unk)
  • Felodipine (Unk)
  • Irbesartan (Unk)
  • Levothyroxine (Unk)
  • Oramorph (Unk)
  • Pantoprazole (Unk)
Patient was hospitalized and became disabled.

Hyponatraemia
on Mar 11, 2014 Female from FR , 76 years of age, was diagnosed with and was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: hyponatraemia. Cymbalta dosage: 60 Mg, Qd.
Multiple concurrent drugs taken:
  • Lyrica (150 Mg, Qd)
  • Rivotril (0.35 Ml (7 Drops), Qd)
  • Lipanthyl (160 Mg, Qd)
  • Amlor (5 Mg, Qd)
  • Debridat /00465201/ (Unk)
  • Doliprane (Unk)
Patient was hospitalized.

Stomatitis Necrotising, Sinusitis, Osteonecrosis, Tooth Loss, Mucosal Infection, Sinus Perforation, Cranial Nerve Disorder, Herpes Virus Infection, Oral Pain
on Mar 10, 2014 Female from US , 50 years of age, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: stomatitis necrotising, sinusitis, osteonecrosis, tooth loss, mucosal infection, sinus perforation, cranial nerve disorder, herpes virus infection, oral pain. Cymbalta dosage: 30 Mg, Qd.

Pain, Hypertension, Dry Mouth
Patient was taking Cymbalta. Patient felt the following Cymbalta side effects: pain, hypertension, dry mouth on Mar 10, 2014 from MX Additional patient health information: Female , 58 years of age, was diagnosed with and. Cymbalta dosage: N/A. Patient was hospitalized.

Hepatitis, Dyspnoea, Diarrhoea
Adverse event was reported on Mar 07, 2014 by a Female taking Cymbalta (Dosage: 60 Mg, Bid) . Location: US , 66 years of age, weighting 180.0 lb, After Cymbalta was administered, patient encountered several Cymbalta side effects: hepatitis, dyspnoea, diarrhoea.

Paresis, Dyspnoea, Myalgia, Blood Creatine Phosphokinase Increased, Gamma-glutamyltransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Pain In Extremity, Hyperbilirubinaemia
on Mar 07, 2014 Male from FR , 70 years of age, was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: paresis, dyspnoea, myalgia, blood creatine phosphokinase increased, gamma-glutamyltransferase increased, back pain, blood alkaline phosphatase increased, pain in extremity, hyperbilirubinaemia. Cymbalta dosage: 30 Mg, Qd.
Associated medications used:
  • Flecaine (30 Mg, Qd)
  • Prednisone (10 Mg, Each Morning)
  • Oxycontin (30 Mg, Bid)
  • Oxinorm /00045603/ (10 Mg, Until 4 Daily)
  • Flecaine (150 Mg, Qd)
  • Inexium /01479302/ (20 Mg, Each Morning)
  • Heptamyl (Unk, Tid)
  • Tardyferon (Unk, Each Morning)
Patient was hospitalized.

Stridor, Cough, Dysgeusia
on Mar 07, 2014 Female from DE , 47 years of age, weighting 198.4 lb, was diagnosed with and was treated with Cymbalta. Patient felt the following Cymbalta side effects: stridor, cough, dysgeusia. Cymbalta dosage: 60 Mg, Qd.
Multiple prescriptions taken:
  • Pregabalin (150 Mg, Tid)
  • Amitriptylinoxide (60 Mg, Qd)
  • Tapentadol (100 Mg, Tid)


Completed Suicide
Patient was taking Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: completed suicide on Mar 06, 2014 from FR Additional patient health information: Female , 45 years of age, . Cymbalta dosage: N/A.
Multiple concurrent drugs taken:
  • Zyprexa


Skin Wrinkling, Eye Swelling, Dry Skin, Yellow Skin, Skin Discolouration
Adverse event was reported on Mar 06, 2014 by a Female taking Cymbalta (Dosage: 30 Mg, Qd) . Location: MX , 45 years of age, Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: skin wrinkling, eye swelling, dry skin, yellow skin, skin discolouration.

Dyspnoea, Tremor, Sleep Disorder, Mood Swings, Bipolar Disorder, Condition Aggravated
on Mar 04, 2014 Female from US , 48 years of age, weighting 336.6 lb, was diagnosed with and was treated with Cymbalta. Patient felt the following Cymbalta side effects: dyspnoea, tremor, sleep disorder, mood swings, bipolar disorder, condition aggravated. Cymbalta dosage: 30 Mg ( 3 Tabs) A Few Weeks Am Po.

Gingivitis, Periodontitis
on Mar 05, 2014 Female from FR , 35 years of age, weighting 110.2 lb, was diagnosed with and was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: gingivitis, periodontitis. Cymbalta dosage: N/A.

Malnutrition, Protein Deficiency
Patient was taking Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: malnutrition, protein deficiency on Mar 04, 2014 from US Additional patient health information: Female , 46 years of age, was diagnosed with and. Cymbalta dosage: 60 Mg, Tid. Patient was hospitalized.

Blood Alkaline Phosphatase Increased
Adverse event was reported on Mar 04, 2014 by a Female taking Cymbalta (Dosage: 60 Mg, Qd) was diagnosed with and. Location: JP , 48 years of age, Patient felt the following Cymbalta side effects: blood alkaline phosphatase increased.

Blood Pressure Increased
on Mar 04, 2014 Male from JP , 75 years of age, was diagnosed with and was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: blood pressure increased. Cymbalta dosage: 20 Mg, Qd.
Multiple concurrent drugs taken:
  • Lyrica (Unk)
  • Voltaren /00372302/
  • Tramadol Hydrochloride And Acetaminophen
  • Nicorandil (10 Mg, Unk)
  • Artist (2.5 Mg, Unk)
  • Nexium /01479302/ (20 Mg, Unk)
  • Clopidogrel Sulfate (75 Mg, Unk)
  • Warfarin Potassium (1 Df, Unk)


Cataract, Presyncope, Abdominal Pain Upper, Vomiting, Diarrhoea, Influenza
on Mar 31, 2014 Female from US , 76 years of age, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: cataract, presyncope, abdominal pain upper, vomiting, diarrhoea, influenza. Cymbalta dosage: 60 Mg, Qd.

1 of 575 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Cymbalta Side Effects

    Did You Have a Cymbalta Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Cymbalta for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative CYMBALTA Names:DULOXETIN

    Active Ingredient: DULOXETIN

    Cymbalta Dosage, Warnings, Usage.

    Side Effects reported to FDA: 14373

    Cymbalta safety alerts: 2005

    Reported deaths: 928

    Reported hospitalizations: 4360

    Cymbalta (duloxetine) Public Health Advisory: Suicidality in Adults Being Treated with Antidepressant Medications

    Audience: Neuropsychiatric healthcare professionals and consumers

    [UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject of a June 30, 2005 Public Health Advisory issued about the risk of suicidality (suicidal thinking or behavior) in adults being treated with antidepressant medications.

    [Posted 07/01/2005] In response to recent scientific publications that report the possibility of increased risk of suicidal behavior in adults treated with antidepressants, the FDA has issued a Public Health Advisory to update patients and healthcare providers with the latest information on this subject. Even before the publication of these recent reports, FDA had already begun the process of reviewing available data to determine whether there is an increased risk of suicidal behavior in adults taking antidepressants. The Agency has asked manufacturers to provide information from their trials using an approach similar to that used in the evaluation of the risk of suicidal behavior in the pediatric population taking antidepressants. This effort will involve hundreds of clinical trials and may take more than a year to complete.

    [July 08, 2005 - Healthcare Professional and Patient Information Sheets - FDA]
    [June 30, 2005 - Public Health Advisory - FDA]
    [June 30, 2005 - Drug Information Page - FDA]

    Latest Cymbalta clinical trials